	Mar 2025	Dec 2024	Mar 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	148.15	176.02	128.64	-15.8%	15.2%
Operating Profit Qtr	25.49	49.16	20.72	-48.1%	23.0%
Net Profit Qtr	117.35	34.93	13.24	236.0%	786.3%
Earning Per Share Adjusted latest Qtr	70.95	21.12	8.01	235.9%	785.8%

* Standalone data

Detailed Results

RPG Life Sciences Ltd.

28 Apr 2025

2157.90

0.46%

Board Meeting

RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Audited Financial Result For Quarter …

BSE India

Audited Financial Result for the Quarter and year ended on March 31, 2025

pdf

RPG Life Sciences Ltd.

23 Apr 2025

2157.90

0.46%

Investor Presentation

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results Earnings Call for audited Financial Results of the Company for the quarter and half year ended Mar 31, 2025 will be held on Tuesday, April 29, 2025 at 3.30 p.m. IST. Please find below the dial-in-details for the said call. Dial-in Details: Indian (Universal) and Mumbai +91 22 6280 1116 +91 22 7115 8017 Location Toll Free Number US 18667462133 UK 08081011573 Singapore 8001012045 Hong Kong 800964448 Diamond Pass Link Link to register- https://tinyurl.com/f62v7vrw The investor presentation shall be shared with the Exchanges separately. You are requested to kindly take the same on record and disseminate appropriately.

pdf

RPG Life Sciences Ltd.

21 Apr 2025

2157.90

0.46%

Board Meeting

RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for Pursuant To Regulation 29 Of …

BSE India

RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 ,inter alia, to consider and approve Pursuant to regulation 29 of the SEBI LODR, 2015 this is to inform you that a meeting of the board of directors of the company is scheduled on Monday April 28 2025 inter alia to- 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025. 2. Recommend dividend, if any, on Equity Shares of the Company for the financial year ended March 31, 2025 Further, pursuant to the 'Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders' of the Company and the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives, is closed from April 1, 2025 and will continue to remain closed till 48 hours after declaration of results on April 28, 2025.

pdf

RPG Life Sciences Ltd.

19 Apr 2025

2157.90

0.46%

Corp. Note

RPG Life Sciences Ltd - 532983 - Format of the Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyRPG Life Sciences Ltd 2CIN NO.L24232MH2007PLC169354 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rajesh Shirambekar Designation: Company Secretary EmailId: rajesh.shirambekar@rpgls.com Name of the Chief Financial Officer: Vishal Shah Designation: Chief Financial officer EmailId: vishal.shah@rpgls.com Date: 19/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

RPG Life Sciences Ltd.

11 Apr 2025

2157.90

0.46%

Company Update

RPG Life Sciences Ltd - 532983 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, …

BSE India

We are enclosing herewith certificate dated April 03, 2025 issued by MUFG Intime India Private Limited Registrar and Transfer Agents, confirming compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Kindly take the same on record.

pdf

RPG Life Sciences Ltd.

08 Apr 2025

2157.90

0.46%

Company Update

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015, we wish to inform you that, on the recommendation of the Nomination and Remuneration Committee, the Board of Directors on April 7, 2025 has approved appointment of Ms Sheetal Gaba as Chief Human Resource Officer (CHRO) in capacity of a Senior Management Personnel of the Company w.e.f April 7, 2025.

pdf

RPG Life Sciences Ltd.

25 Mar 2025

2157.90

0.46%

SAST

RPG Life Sciences Ltd - 532983 - Closure of Trading Window

BSE India

This is to inform you that pursuant to ''Code of Fair Disclosure, Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders'' of the Company and SEBI (Prohibition of Insiders Trading) Regulation, 2015 the Trading window for dealing in securities of the company by Designated Persons and their immediate relatives shall remain Closed from Tuesday April 1, 2025 until 48 hours after the declaration of audited financial results by the Company for the year ending on March 31, 2025. The date of Board Meeting of the Company for consideration and declaration of audited financial results for the year ending on March 31, 2025 will be intimated in due course

pdf

Is RPG Life Sciences Ltd. worth buying?

79 Votes:

Buy 72.15%

Sell 17.72%

Hold 10.13%